Ecolyse
Ecolyse is a privately-held biotechnology firm founded in 2007 in College Station, Texas, developing microbiological products and services for the energy, industrial, and health sectors. Available data is limited; the only documented financing is a 2012 NSF grant.
- Company typePrivate
- Founded2007
- HeadquartersCollege Station, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Ecolyse does
Ecolyse is a privately-held biotechnology firm founded in 2007 and headquartered in College Station, Texas. According to available firmographic data, the company develops microbiological products and services for clients operating in three distinct verticals: the energy sector, the industrial sector, and the health sector. Its functional positioning sits at the intersection of applied microbiology and industrial bioprocessing, suggesting a B2B technology-and-services model rather than a consumer-facing offering.
Detailed information on Ecolyse's specific product portfolio, service lines, go-to-market motion, pricing mechanics, customer profile, and revenue model is not available in the supplied input. The company's public website (ecolyse.com) currently displays a verification/loading page rather than substantive corporate or technical content, and no management team bios, customer logos, partnership announcements, patent disclosures, certification details, or product specifications were captured in the source material. The only documented financial event in the data is a July 2012 funding round of $821,515 from the National Science Foundation, consistent with a non-dilutive, R&D-oriented funding posture typical of early-stage SBIR/STTR-style recipients.
Ecolyse is classified as a small for-profit private company with 11-50 employees. Given the absence of any more recent disclosed funding event, product launch, leadership change, partnership, or commercial milestone in the input, the available evidence is insufficient to characterize current commercial traction, revenue trajectory, or operating status with confidence. The 12+ year gap since the last documented financing event and the non-functional corporate website are themselves material data points for any diligence process.
Ecolyse firmographics
Firmographics- Name
- Ecolyse
- Website
- https://ecolyse.com
- Company type
- Private
- Founded year
- 2007
- Headcount range
- 11–50 employees
- Short description
- Ecolyse is a privately-held biotechnology firm founded in 2007 in College Station, Texas, developing microbiological products and services for the energy, industrial, and health sectors. Available data is limited; the only documented financing is a 2012 NSF grant.
- Ownership category
- akta.pro rank
Ecolyse industry classification
Industry- Product category
- Industrial Microbiology / Bioremediation
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids) (EUAAAIAL)
Keywords
Where Ecolyse is headquartered
LocationHeadquarters
- HQ city
- College Station
- HQ country
- United States
- HQ region
- North America
Markets served
Ecolyse business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Ecolyse product offering
Product offeringCore offering
Ecolyse offers microbiological products and services for the energy, industrial, and health sectors. The company develops and delivers biological/microbe-based solutions applicable across energy, industrial, and healthcare markets, leveraging microbial science to address sector-specific needs.
Differentiator
Problem solved
Functional benefit
Products and services
- Microbiological Products and Services
Companies that use Ecolyse
Customer profileIdeal customer profiles3 records
Ecolyse technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Ecolyse partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights2 records
Ecolyse competitors and assessment
Company assessmentBroad incumbents
- Novonesis (formerly Novozymes): Global leader in industrial enzymes and microbial solutions across energy, agriculture, and health. Highly comparable as a broad incumbent supplying microbiological inputs into the same verticals Ecolyse targets, but at vastly greater scale and product breadth.
- DSM-Firmenich: Global ingredient company with extensive industrial biotechnology and microbiome/health portfolios. Comparable as a broad incumbent serving health, food, and industrial end markets with fermentation-derived products.
- IFF (International Flavors & Fragrances): Major ingredients producer (now including the former DuPont Industrial Biosciences) with a large microbial and enzyme portfolio for energy, industrial, and consumer health applications. Comparable as a broad incumbent with overlapping microbial product lines.
- Ginkgo Bioworks: Horizontal synthetic biology platform that programs microbial strains for diverse industrial applications, including energy, health, and industrial biotech. Comparable as a broad incumbent platform with overlapping end markets and similar enabling technology.
Emerging players
- BioVectra: CDMO specializing in microbial fermentation and biologics manufacturing for health and industrial customers. Comparable as a similarly sized contract manufacturer using microbiological processes for health and industrial applications.
- Eligo Bioscience: Developer of engineered microbial therapeutics (phage- and bacteria-based) for microbiome-related health applications. Comparable as an emerging player building microbial products aimed at the health sector mentioned in Ecolyse's offering.
- Zymergen (now part of Ginkgo Bioworks): Historically a synthetic biology company using engineered microbes for industrial applications; now integrated into Ginkgo. Comparable as a developer of microbiological solutions spanning industrial and consumer verticals.
Others
- Amyris: Industrial biotech company using engineered microbes to produce ingredients for health, beauty, and clean energy markets. Highly comparable in its use of microbial fermentation to serve health and energy verticals, though currently undergoing a corporate restructuring.
Direct peers
- Codexis: Engineers enzymes and microbial strains for industrial bioprocessing applications across pharmaceuticals, food, and sustainable chemicals. Directly comparable as a developer of microbial/enzymatic inputs sold into industrial and health-adjacent end markets.
- LanzaTech: Develops gas-fermenting microbes that convert industrial off-gases into fuels and chemicals for the energy sector. Directly comparable to Ecolyse's energy-focused microbiological products and similar in its use of engineered microbial platforms.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
Ecolyse social profiles
Digital presenceEcolyse financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ecolyse leadership team
Management profileNumber of profiles
Ecolyse funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ecolyse M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ecolyse
What does Ecolyse do?
Ecolyse offers microbiological products and services for the energy, industrial, and health sectors. The company develops and delivers biological/microbe-based solutions applicable across energy, industrial, and healthcare markets, leveraging microbial science to address sector-specific needs.
When was Ecolyse founded?
Ecolyse was founded in 2007. It employs 11 to 50 people.
Where is Ecolyse based?
Ecolyse is headquartered in College Station, United States, in the North America region.
Who are Ecolyse's main competitors?
Broad incumbents on record are Novonesis (formerly Novozymes), DSM-Firmenich, IFF (International Flavors & Fragrances) and Ginkgo Bioworks. Emerging players are BioVectra, Eligo Bioscience and Zymergen (now part of Ginkgo Bioworks). Amyris is listed as an others. Direct peers are Codexis and LanzaTech.
Does Ecolyse have an API?
No public API is recorded for Ecolyse.
What industry is Ecolyse in?
Ecolyse's product category is Industrial Microbiology / Bioremediation. Its primary akta.pro industry code is EUAAAIAL, Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids). Its SIC code is 2836.